chr12-79690184-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002583.4(PAWR):āc.61G>Cā(p.Glu21Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000355 in 1,533,376 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00022 ( 0 hom., cov: 31)
Exomes š: 0.00037 ( 1 hom. )
Consequence
PAWR
NM_002583.4 missense
NM_002583.4 missense
Scores
4
2
13
Clinical Significance
Conservation
PhyloP100: 6.05
Genes affected
PAWR (HGNC:8614): (pro-apoptotic WT1 regulator) This gene encodes a tumor suppressor protein that selectively induces apoptosis in cancer cells through intracellular and extracellular mechanisms. The intracellular mechanism involves the inhibition of pro-survival pathways and the activation of Fas-mediated apoptosis, while the extracellular mechanism involves the binding of a secreted form of this protein to glucose regulated protein 78 (GRP78) on the cell surface, which leads to activation of the extrinsic apoptotic pathway. This gene is located on the unstable human chromosomal 12q21 region and is often deleted or mutated different tumors. The encoded protein also plays an important role in the progression of age-related diseases. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.1871657).
BS2
High AC in GnomAd4 at 34 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PAWR | NM_002583.4 | c.61G>C | p.Glu21Gln | missense_variant | 2/7 | ENST00000328827.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PAWR | ENST00000328827.9 | c.61G>C | p.Glu21Gln | missense_variant | 2/7 | 1 | NM_002583.4 | P1 | |
PPP1R12A-AS2 | ENST00000551995.1 | n.41C>G | non_coding_transcript_exon_variant | 1/2 | 5 | ||||
PAWR | ENST00000548426.1 | c.61G>C | p.Glu21Gln | missense_variant | 2/2 | 3 | |||
PAWR | ENST00000552637.1 | c.61G>C | p.Glu21Gln | missense_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000224 AC: 34AN: 151994Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
34
AN:
151994
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000184 AC: 24AN: 130152Hom.: 0 AF XY: 0.000221 AC XY: 16AN XY: 72352
GnomAD3 exomes
AF:
AC:
24
AN:
130152
Hom.:
AF XY:
AC XY:
16
AN XY:
72352
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000369 AC: 510AN: 1381382Hom.: 1 Cov.: 32 AF XY: 0.000378 AC XY: 258AN XY: 682796
GnomAD4 exome
AF:
AC:
510
AN:
1381382
Hom.:
Cov.:
32
AF XY:
AC XY:
258
AN XY:
682796
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000224 AC: 34AN: 151994Hom.: 0 Cov.: 31 AF XY: 0.000242 AC XY: 18AN XY: 74248
GnomAD4 genome
AF:
AC:
34
AN:
151994
Hom.:
Cov.:
31
AF XY:
AC XY:
18
AN XY:
74248
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
11
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.61G>C (p.E21Q) alteration is located in exon 2 (coding exon 1) of the PAWR gene. This alteration results from a G to C substitution at nucleotide position 61, causing the glutamic acid (E) at amino acid position 21 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
T;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;.
MutationTaster
Benign
D
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;D;D
REVEL
Benign
Sift
Pathogenic
D;D;D
Sift4G
Benign
T;.;.
Polyphen
D;.;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at